Cleared Special

K152957 - MultiCross Catheter

K152957 is an FDA 510(k) clearance for MultiCross Catheter, manufactured by Roxwood Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Special 510(k) pathway after a 149-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2016
Decision
149d
Days
Class 2
Risk

K152957 is an FDA 510(k) clearance for the MultiCross Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Roxwood Medical, Inc. (Redwood City, US). The FDA issued a Cleared decision on March 4, 2016 after a review of 149 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Roxwood Medical, Inc. devices

FDA 510(k) Submission Details - K152957

510(k) Number K152957 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 07, 2015
Decision Date March 04, 2016
Days to Decision 149 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
24d slower than avg
Panel avg: 125d · This submission: 149d
Pathway characteristics
Modification to existing cleared device.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 651
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K152957.
SIDEKICK and USHER Support Catheters
K161986 · Bard Peripheral Vascular, Inc. · Aug 2016
ASAHI Corsair Armet
K161362 · Asahi Intecc Co., Ltd. · Jun 2016
ASAHI Corsair Armet
K152249 · Asahi Intecc Co., Ltd. · Mar 2016
ASAHI Caravel
K152447 · Asahi Intecc Co., Ltd. · Jan 2016
Stingray LP Catheter
K152401 · Boston Scientific Corporation · Dec 2015
Lantern Delivery Microcatheter
K152840 · Penumbra, Inc. · Dec 2015